Research progress of epigallocatechin-3-gallate (EGCG) on anti-pathogenic microbes and immune regulation activities
Zijuan Zhao, Meiyan Feng, Juan Wan, Xin Zheng, Cuiqin Teng, Xinya Xie, Wenjing Pan, Baozhu Hu, Jianan Huang, Zhonghua Liu, Jianhua Wu, Shuxian Cai
Abstract
. At present, the bioavailability of EGCG can be improved to some extent using nanostructured drug delivery systems and molecular modification technology in combination with other drugs. This study provides a theoretical basis for the development of EGCG as an adjuvant drug for anti-pathogenic microorganisms.
Topics & Concepts
Epigallocatechin gallateImmune systemBiologyCoronavirus disease 2019 (COVID-19)VirusGallateVirologyMicrobiologyPolyphenolImmunologyBiochemistryMedicinePharmacologyInfectious disease (medical specialty)DiseaseAntioxidantPathologyTea Polyphenols and EffectsTryptophan and brain disordersMedicinal Plant Research